Home | About Us | News & RESOURCES | CME Opportunities | Residents & MedICAL Students | Tar Wars | Quarterly Journal
News & Resources

Save the Date - Tennessee Child Heatlh Week - October 4-10, 2010

Tennessee State Loan Repayment Program (TSLRP)

Patient Safety Quality Improvement Organization Support Center MedQIC Update

          -August 2010

U.S. Food and Drug Administration Updates for Health Professionals

          -June 2010

          -May 2010 (update)

          -May 2010

-April 2010

-March 2010

-February 2010

-January 2010

      
MedWatch - The FDA Safety Information & Adverse Event Reporting Program
           -July 2010 (update)

           -July 2010

           -June 2010

           -May 2010

           -April 2010

           -March 2010

    

Required Official Immunization Certificate for Schools

            -Update April 2010

      

Volunteer State Health Plan (VSHP) Rate Reduction


Expansion of outpatient radiology prior authorization requirements for AmeriChoice by UnitedHealthcare effective February 15, 2010


Radiology Prior Authorization Program Frequently Asked Questions (FAQ) For AmeriChoice by UnitedHealthcare, Tennessee

Message from Jim King, M.D., Chair, FamMedPAC


Interest-Free Loans Available to Help Physicians Adopt Electronic Health Records


FTC Extends Enforcement Deadine for Identity Theft Red Flags Rule


Tennessee Antiviral Distribution Network 2009 H1N1 Response


Important Information for TennCare Providers
Regarding Authorization Requirements for Tamiflu


TN AFP Partnership with (Governor's Books From Birth Foundation)


Important New TennCare Information for Physicians


Updated information on rule change related to sports physicals

Tennessee's New Smoke-free Workplace Law

CoverTN

Useful Links

 

 

FDA MedWatch - June 2010 FDA Patient Safety News now available

 

MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA Patient Safety News (PSN) is a monthly video news show for healthcare professionals. It covers significant safety alerts, recalls, new product approvals, and offers important tips on protecting patients. Read the complete stories and watch or download the video program at www.fda.gov/psn. You may have already received notification of some of these safety issues through the MedWatch E-list. However, many of these PSN stories contain video footage and demonstrations that may be especially useful to clinicians and educators in healthcare facilities and academic institutions.

Stories in the June 2010 edition include:

New Formulation for OxyContin

Reformulation makes it more difficult to misuse or abuse the drug…

First Absorbable Sealant Patch for Cardiovascular Surgery

TachoSil provides surgeons with an additional tool to help control bleeding…

Reduced Effect from Plavix in Some Patients

Tests are available to identify "poor metabolizers" of the drug based on genetic makeup…

Muscle Injury from High Doses of Zocor

Ongoing safety review indicates increased risk of muscle injury with 80 mg. dose of simvastatin…

Companies to Stop Marketing Unapproved Nitroglycerin Tablets

Hospitals and pharmacies that buy unapproved nitroglycerin tablets from Glenmark Generics and Konec Inc. will need to switch to approved ones…

Boxed Warning for Exjade
Warning highlights the need for close monitoring of a patient's renal and hepatic function…

Hemolysis Risk with WinRho SDF

Closely monitor patients for signs and symptoms of hemolysis…

Avoiding Problems with Temporary Cardiac Pacing
An FDA article from Nursing2010 on ways to avoid misconnections, disconnections, and lead fractures…

Caution about Sexual Enhancement Supplements
“All natural" supplements may contain ingredients that could pose a serious health risk…

Phase-Out of CFC Inhalers

Patients using Aerobid, Combivent or Maxair should talk to their doctors about switching to another product…

You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

FDAHHS

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · 10903 New Hampshire Ave MD 20993 · 800-439-1420